The use of the antifungal agent miconazole as an inhibitor of Blastocystis hominis growth in Entamoeba histolytica/E. dispar cultures
Open Access
- 1 June 2007
- journal article
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 49 (3) , 201-202
Abstract
In regions with high prevalence, Blastocystis hominis is frequently found in association with Entamoeba histolytica/E. dispar in xenic cultures. Its exacerbated growth is often superimposed on the growth of amebas, thus impeding the continuation of the amebas in the culture, within a few generations. The present study reports on the excellent efficacy (100%) of the antifungal agent miconazole in eliminating B. hominis from cultures of E. histolytica/E. dispar, thereby maintaining the integrity of the trophozoites of the amebas. Nystatin presented low efficacy (33.3%).Keywords
This publication has 5 references indexed in Scilit:
- Methods for Cultivation of Luminal Parasitic Protists of Clinical ImportanceClinical Microbiology Reviews, 2002
- Effect of Trimethoprim-Sulfamethaxazole in Blastocystis Hominis InfectionAmerican Journal of Gastroenterology, 1999
- Epidemiology of Blastocystis hominis infection in Papua New Guinea: age-prevalence and associations with other parasitesPathogens and Global Health, 1992
- A method of freeing cultures of entamoeba histolytica from contamination with blastocystisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1956
- On the Cultivation ofEntamoeba histolyticaand some other Entozoic AmoebaeParasitology, 1926